Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2,235 evidence items · page 81 / 90

9.5 secondsDemographic-based record retrieval in the EMRS had a mean record retrieval speed of 9.5 seconds in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

11.58 odds_ratioTransferring into facilities while already receiving ART was associated with increased odds of loss to follow-up (LTFU) (adjusted odds ratio 11.58; 95% CI: 8.23–16.29).

KenyaVIH/sidaobserved October 1, 2016, to June 30, 2017published 2021AIDS research and human retrovirusesPubMeddocument of 6 observations

2.3 ORGC haplotype was associated with higher odds of having underweight (OR, 2.30; 95% CI, 1.89–4.71; P=0.006) in antiretroviral treatment-experienced injection substance users.

KenyaVIH/sidapublished 2020Ethiopian journal of health sciencesPubMeddocument of 7 observations

5,610 facility-quartersA total of 5,610 unique facility-quarters were extracted from the Kenya Health Information System (KHIS) for HIV data assessment.

KenyaVIH/sidaobserved January 2011 to June 2018published 2023BMC health services researchPubMeddocument of 3 observations

99 per_one_million_T_cellsIn a cohort of Kenyan children (n = 72), the median number of intact HIV proviral copies was 99 per one million T cells between one- and two-years post-ART initiation.

KenyaVIH/sidapublished 2023VirusesPubMeddocument of 3 observations

62 %The proportion of adolescents and young people living with HIV on antiretroviral therapy whose viral load was resuppressed on repeat testing improved to 62% during the implementation period.

KenyaVIH/sidaobserved from March 2019 to July 2020published 2022BMJ open qualityPubMeddocument of 8 observations

0.57 IRRThe incidence rate ratio (IRR) for HIV acquisition after clinic reopening versus before, adjusted for study site and participant characteristics, was 0.57 (95% CrI = 0.23–1.33) among gay, bisexual, and other men who have sex with men and transgender women in Kenya.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 6 observations

4.18 adjusted_risk_ratioDrug resistance penalty score (DR-PS) ≥ 30 was associated with history of viremia ≥ 1000 copies/mL (adjusted risk ratio = 4.18).

KenyaVIH/sidaobserved 2019 to 2023published 2025VirusesPubMeddocument of 8 observations

157 casesThere were 157 total HIV-positive youth in the Community Health Initiative in Kisumu County in 2018.

KenyaVIH/sidaobserved 2018published 2022AIDS and behaviorPubMeddocument of 6 observations

127 USDMean cost per contact for HIV services to key populations was US$127 in Kenya and US$279 in Malawi.

Kenya · MalawiVIH/sidaobserved FY2019published 2023Global health, science and practicePubMeddocument of 4 observations

17.1 %Overall weighted HIV prevalence was 17.1% among married women in Siaya County, Kenya.

KenyaVIH/sidaobserved 2011-2022published 2025BMC public healthPubMeddocument of 12 observations

14 %Anaemia was present in 22 (14%) of 162 HIV-attributed infant or child deaths.

Kenyaanémie · VIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

2.05 per_100_person_yearsHIV incidence rate was 2.05 per 100 person-years (95% CrI = 1.22–3.26, n = 14) during COVID-19-related clinic closures among gay, bisexual, and other men who have sex with men and transgender women in Kenya.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 6 observations

497 individualsThe study included 497 HIV-positive women aged 19–49 years who had sex in the past six months.

KenyaVIH/sidaobserved 2012published 2019Journal of HIV and AIDSeurope_pmcdocument of 2 observationsDOI 10.16966/2380-5536.166

17 %Minority resistance variants evolved in 17% of participants in a cohort of Kenyan children and adolescents living with HIV failing first-line antiretroviral therapy.

KenyaVIH/sidapublished 2023VirusesPubMeddocument of 6 observations

9.5 per_yearHalf of the 200 HIV-negative women scored ≥5 on a validated tool that would correspond to an expected HIV incidence of 9.5% per year.

KenyaVIH/sidaobserved 2019–2020published 2021Journal of the International AIDS SocietyPubMeddocument of 5 observations

0.463 AUROCThe model for pregnant and postpartum women with HIV with a new HIV diagnosis demonstrated discrimination with an area under the curve of receiver operating characteristic of 0.463.

KenyaVIH/sidapublished 2025AIDS and behaviorPubMeddocument of 13 observations

23 %Target setting explained 23–34% of service volume variation.

KenyaVIH/sidapublished 2025PloS onePubMeddocument of 8 observations

2.49 odds_ratioCD4 C868T was associated with an increased incidence of HIV-1 infection (P = .005, log-rank test; P = .009, Wilcoxon test), with an odds ratio of 2.49 (P = .009).

KenyaVIH/sidapublished 2009The Journal of infectious diseaseseurope_pmcdocument of 2 observationsDOI 10.1086/597616

1,300,000 peopleApproximately 1.3 million people in Kenya are living with HIV.

KenyaVIH/sidapublished 2026JMIR research protocolsPubMeddocument of 4 observations

40 %The proportion of vitamin D deficiency was 40.0% among HAART-naive participants.

KenyaVIH/sidapublished 2024BMC infectious diseasesPubMeddocument of 10 observations

20.6 percent_per_yearClade D infection is associated with a CD4 decline of 20.6% per year compared to 13.4% per year for clade A1 in a Nairobi-based prospective female sex worker cohort from 1985 to 2004.

KenyaVIH/sidaobserved 1985-2004published 2012PloS oneeurope_pmcdocument of 2 observationsDOI 10.1371/journal.pone.0049797

95.4 %Among 3891 PLHIV with documented IPT treatment outcomes in Kenya between July 2015 and June 2018, 3712 (95.4%) completed their IPT treatment.

KenyaVIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

99.2 %654 (99.2%) of the 659 decedents with blood samples collected were tested for HIV.

KenyaVIH/sidaobserved 2019published 2022BMC public healthPubMeddocument of 6 observations

0.6 %HIV prevalence was 0.6% among patients with risk-score ≤9.

KenyaVIH/sidaobserved September 2017 to May 2018published 2021AIDS and behaviorPubMeddocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.